We are live on ! Find out more
CCA

Cravens & Co Advisors Portfolio holdings

AUM $154M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+2.86%
1 Year Est. Return
+17.67%
3 Year Est. Return
+52.1%
5 Year Est. Return
10 Year Est. Return
AUM
$153M
AUM Growth
+$6.22M
Cap. Flow
-$211K
Cap. Flow %
-0.14%
Top 10 Hldgs %
64.41%
Holding
66
New
8
Increased
11
Reduced
38
Closed
3

Sector Composition

Rank Sector Weight
1 Financials 8.9%
2 Technology 6.14%
3 Healthcare 4.83%
4 Communication Services 3.52%
5 Industrials 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
51
Bristol-Myers Squibb
BMY
$127B
$307K 0.2%
5,491
-23
-0.4% -$1.11K
DUK icon
52
Duke Energy
DUK
$102B
$304K 0.2%
2,593
-69
-3% -$8.43K
CNQ icon
53
Canadian Natural Resources
CNQ
$96.9B
$301K 0.2%
9,089
-201
-2% -$6.52K
SPTS icon
54
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.07B
$295K 0.19%
+10,073
New +$295K
VOE icon
55
Vanguard Mid-Cap Value ETF
VOE
$23.7B
$286K 0.19%
1,560
VALE icon
56
Vale
VALE
$62.9B
$285K 0.19%
20,202
-89
-0.4% -$1.08K
SPTI icon
57
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.4B
$263K 0.17%
+9,112
New +$264K
CGGO icon
58
Capital Group Global Growth Equity ETF
CGGO
$11.2B
$223K 0.15%
6,194
-66
-1% -$2.28K
ASTS icon
59
AST SpaceMobile
ASTS
$16.8B
$223K 0.15%
+2,409
New +$172K
IBB icon
60
iShares Biotechnology ETF
IBB
$9.31B
$214K 0.14%
+1,250
New +$203K
XLE icon
61
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$205K 0.13%
+4,364
New +$194K
MSOS icon
62
AdvisorShares Pure US Cannabis ETF
MSOS
$864M
$85.7K 0.06%
17,818
+850
+5% +$3.79K
PSEC icon
63
Prospect Capital
PSEC
$1.06B
$56K 0.04%
20,000
BAC icon
64
Bank of America
BAC
$435B
-6,700
Closed -$346K
CCI icon
65
Crown Castle
CCI
$32.7B
-2,230
Closed -$215K
IP icon
66
International Paper
IP
$22.3B
-6,243
Closed -$290K

Similar funds

Cravens & Co Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Cravens & Co Advisors held 66 positions worth $153M, up 4.2% from $146M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Cravens & Co Advisors's Q4 2025 filing shows 8 new, 11 increased, 38 reduced and 3 closed positions. Its largest new stake was JPMorgan Ultra-Short Income ETF: 104,395 shares worth $5.29M. The largest sale was PGIM Ultra Short Bond ETF, an estimated $3.73M.

By sector, the portfolio is most concentrated in Financials at 8.9% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.

  • Cravens & Co Advisors's largest Q4 2025 buy was JPMorgan Ultra-Short Income ETF: 104,395 shares worth $5.29M.
  • Cravens & Co Advisors added most to Dimensional Emerging Markets Core Equity 2 ETF in Q4 2025, an estimated $355K increase.
  • Cravens & Co Advisors's biggest Q4 2025 reduction was PGIM Ultra Short Bond ETF, cutting an estimated $3.73M.
  • Cravens & Co Advisors fully exited Bank of America in Q4 2025, selling an estimated $346K.
  • Cravens & Co Advisors's ten largest holdings make up 64% of its $153M portfolio in Q4 2025.
  • Cravens & Co Advisors opened 8 new positions and closed 3 in Q4 2025.
  • Cravens & Co Advisors's portfolio value rose 4.2% quarter-over-quarter to $153M.

Based on Cravens & Co Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.